Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clotet

Showing results (161-170 of 263) with videos related to

Pageof 27
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 5, 2002
Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997)Ma L Pedro-Botet, J M Mòdol, X Vallés, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Scandinavian Journal of Infectious Diseases|June 25, 1999
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+ lymphocytesJ Romeu, M Balagué, L Ruiz, et al.
AIDS (London, England)|August 1, 1996
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)J C Schmit, L Ruiz, B Clotet, et al.
Medicina Clinica|April 10, 1979
[Granulomatous hepatitis. Etiologic study of 107 cases (author's transl)]J Vilaseca, J Guardia, A Cuxart, et al.
HIV Medicine|June 17, 2016
Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-upS Videla, G Sirera, A Ornelas, et al.
Medicina Clinica|January 13, 1990
[Evidence of HTLV-1 infection in different groups at risk in Barcelona]V Soriano, J Tor, A Ribera, et al.
HIV Clinical Trials|February 11, 2009
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiatedA Bonjoch, M J Buzon, J M Llibre, et al.
AIDS (London, England)|August 26, 1998
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infectionC Vidal, F García, J Romeu, et al.
HIV Medicine|March 6, 2010
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment changeJ Reekie, A Mocroft, B Ledergerber, et al.
Pageof 27

Showing results (161-170 of 263) with videos related to

Sort By:
Pageof 27
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 5, 2002
Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997)Ma L Pedro-Botet, J M Mòdol, X Vallés, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Scandinavian Journal of Infectious Diseases|June 25, 1999
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+ lymphocytesJ Romeu, M Balagué, L Ruiz, et al.
AIDS (London, England)|August 1, 1996
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)J C Schmit, L Ruiz, B Clotet, et al.
Medicina Clinica|April 10, 1979
[Granulomatous hepatitis. Etiologic study of 107 cases (author's transl)]J Vilaseca, J Guardia, A Cuxart, et al.
HIV Medicine|June 17, 2016
Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-upS Videla, G Sirera, A Ornelas, et al.
Medicina Clinica|January 13, 1990
[Evidence of HTLV-1 infection in different groups at risk in Barcelona]V Soriano, J Tor, A Ribera, et al.
HIV Clinical Trials|February 11, 2009
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiatedA Bonjoch, M J Buzon, J M Llibre, et al.
AIDS (London, England)|August 26, 1998
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infectionC Vidal, F García, J Romeu, et al.
HIV Medicine|March 6, 2010
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment changeJ Reekie, A Mocroft, B Ledergerber, et al.
Pageof 27